Inherited variants in the <i>MC1R</i> gene and survival from cutaneous melanoma: a BioGenoMEL study
John R. Davies(St James's University Hospital), Julia Newton‐Bishop(University of Leeds), Nelleke A. Gruis(Leiden University), Dirk Schadendorf(National Center for Tumor Diseases), Philippe Saïag(Université de Versailles Saint-Quentin-en-Yvelines), Paola Ghiorzo(Ospedale Policlinico San Martino), Paul Affleck(University of Leeds), Kairen Kukalizch(University of Leeds), Antje Sucker(German Cancer Research Center), Mark Harland(Cancer Research UK), Remco van Doorn(Vrije Universiteit Amsterdam), Juliette A. Randerson‐Moor(University of Leeds), Ichiro Okamoto(Medical University of Vienna), Eduardo Nagore(Valencia Catholic University Saint Vincent Martyr), Zighereda Ogbah(Instituto de Salud Carlos III), Jennifer H. Barrett(University of Leeds), Dace Pjanova(Latvian Biomedical Research and Study Centre), Veronica Höiom(Karolinska Institutet), Paola Queirolo, Nadem Soufir(Inserm), Aija Ozola(Latvian Biomedical Research and Study Centre), Susana Puig(Instituto de Salud Carlos III), Peter A. Kanetsky(Cancer Research And Biostatistics), Rajiv Kumar(Army Hospital Research and Referral), D. Timothy Bishop(University of Leeds), Judith Wendt(University of Leeds), Zaida García‐Casado(Fundación Instituto Valenciano de Oncología), Johan Hansson(Karolinska Institutet), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust)
Cited by 69
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k